| Literature DB >> 29925698 |
Daneeya Ekapopphan1, Athicha Srisutthakarn1, Walasinee Moonarmart2, Ruangrat Buddhirongawatr2, Norasuthi Bangphoomi1.
Abstract
This study aims to determine the microbiological profile and risk factors associated with antimicrobial-resistant bacteria in canine severe corneal ulcers. Thirty-two corneal and conjunctival swabs were collected from dogs with diagnosed severe corneal ulcers that presented to Prasu-Arthorn veterinary teaching hospital in Nakhon Pathom, Thailand from June 2015 to June 2016. Microorganisms were identified by means of genotypic and phenotypic approaches. Of 32 ulcers sampled, 26 (81.3%) yielded culturable microorganisms with 24 bacterial isolates and 7 fungal isolates. The most commonly isolated bacteria were Staphylococcus spp. (45.8%, 11/24) and Pseudomonas aeruginosa (20.8%, 5/24). Out of 11 staphylococcal isolates identified, 10 carried the mecA gene providing methicillin resistance. The extended-spectrum β-lactamase (ESBL) encoding genes blaCTX-M and blaVEB-1 were found in an Acinetobacter lwoffii isolate, and blaSHV was found in a P. aeruginosa isolate. Based on the Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint criteria, minimum inhibitory concentrations values showed that all bacteria, except for staphylococci, were susceptible to current ophthalmic antibiotics. More than 50% of staphylococci were resistant to all generations of fluoroquinolones and fusidic acid. Chloramphenicol was highly active against staphylococci (81.3% susceptible). The width (P=0.02) and the depth (P=0.04) of ulcers predicted greater risk of yielding resistant bacteria. The identification of antimicrobial-resistant bacteria prompts practitioners to be prudent when choosing ophthalmic antibiotics for severe corneal ulcers.Entities:
Keywords: antimicrobial susceptibility; canine severe corneal ulcer; ophthalmic antibiotic; risk factor
Mesh:
Substances:
Year: 2018 PMID: 29925698 PMCID: PMC6115253 DOI: 10.1292/jvms.18-0045
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Isolation of microorganisms and clinical characteristics of corneal ulcers in dogs
| Clinical factor | No. (%) of dogs with positive | No. (%) of dogs with positive | |
|---|---|---|---|
| Affected eye | |||
| OD (right eye) | 13 (68.4) | 4 (57.1) | |
| OS (left eye) | 6 (31.6) | 3 (42.9) | |
| Ulcer depth >50% | 18 (94.7) | 4 (57.1) | |
| Ulcer area >50% | 12 (63.2) | 4 (57.1) | |
| Corneal edema >50% | 15 (79.0) | 5 (71.4) | |
| Keratomalacia | 14 (73.7) | 5 (71.4) | |
| Severity grade | |||
| Mild aqueous flare | 1 (5.3) | 0 | |
| Moderate to marked aqueous flare | 5 (26.3) | 3 (42.9) | |
| Hypopyon or hyphema | 12 (63.2) | 4 (57.1) | |
| Keratomalacia with deep ulcer | 8 (42.1) | 2 (28.6) | |
MIC range and percentage of resistant isolates (based on CLSI and EUCAST breakpoint) to selected ophthalmic antibiotics
| Drug | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC
range( | % Resistant | MIC
range( | % Resistant | MIC
range( | % Resistant | MIC
range( | % Resistant | MIC
range( | % Resistant | MIC
range( | % Resistant | |||||||
| CLSI | EUCAST | CLSI | EUCAST | CLSI | EUCAST | CLSI | EUCAST | CLSI | EUCAST | CLSI | EUCAST | |||||||
| Gentamicin | ≤0.5–16 | 27.3 | 81.8 | ≤0.5–4 | NA | NA | ≤0.5–2 | 0 | 0 | ≤0.5 | 0 | 0 | ≤0.5 | NA | NA | 1 | 0 | 0 |
| Tobramycin | ≤0.5–16 | 27.3 | 90.9 | 2–8 | NA | NA | ≤0.5 | 0 | 0 | ≤0.5–4 | 0 | 0 | ≤0.5 | NA | NA | 1 | 0 | 0 |
| Chloramphenicol | 4–64 | 18.2 | 36.4 | 2–4 | 0 | 0 | 64 | NA | NA | 8–16 | 0 | 33.3a) | ≤0.5 | NA | NA | 1 | NA | NA |
| Polymyxin-B | 8–≥256 | NAc) | NA | 4–32 | NA | NA | 2 | 0 | NA | ≤0.5–≥256 | NA | NA | 2 | NA | NA | 1 | 0 | NA |
| Ciprofloxacin | ≤0.5–64 | 54.6 | 54.6 | ≤0.5 | NA | NA | ≤0.5 | 0 | 0 | ≤0.5 | 0 | 0 | ≤0.5 | NA | NA | 1 | 0 | 0 |
| Levofloxacin | ≤0.5–16 | 54.6 | 54.6 | ≤0.5 | NA | 0 | ≤0.5 | 0 | 0 | ≤0.5 | 0 | 0 | ≤0.5 | NA | NA | 1 | 0 | 0 |
| Moxifloxacin | ≤0.5–4 | 54.6 | 54.6 | ≤0.5 | NA | NA | 1–2 | NA | NA | ≤0.5–1 | NA | 33.3b) | ≤0.5 | NA | NA | ≤0.5 | NA | NA |
| Fusidic acid | ≤0.5–≥256 | NA | 72.7 | 8–64 | NA | NA | ≥256 | NA | NA | ≥256 | NA | NA | ≥256 | NA | NA | ≥256 | NA | NA |
a) Enterobacter cloacae isolate was resistant to moxifloxacin. b) Serratia marcescens isolate was resistant to chloramphenicol. c) NA, not applicable.
Risk factors associated with antimicrobial-resistant bacteria in severe corneal ulcers of dogs
| Variables | AMR bacteria | Odds ratio | Fungi | Odds ratio | |||||
|---|---|---|---|---|---|---|---|---|---|
| + | − | + | − | ||||||
| Sex | 3.71 (0.82–16.84) | 0.09 | 1.7 (0.31–9.22) | 0.54 | |||||
| Male | 4 | 13 | 3 | 14 | |||||
| Female | 8 | 7 | 4 | 11 | |||||
| Age group | 0.71 (0.17–3.03) | 0.65 | 1.7 (0.31–9.22) | 0.54 | |||||
| 1–10 years old | 7 | 10 | 3 | 14 | |||||
| <1 or >10 years old | 5 | 10 | 4 | 11 | |||||
| Ulcer area | 9 (1.14–57.12) | 0.02* | 1.27 (0.79–8.3) | 0.81 | |||||
| 0–75% corneal area | 6 | 18 | 5 | 19 | |||||
| >75% corneal area | 6 | 2 | 2 | 6 | |||||
| Ulcer depth | 6.11 (1.06–35.35) | 0.04* | 0.89 (0.76–4.85) | 0.9 | |||||
| 0–75% corneal depth | 2 | 11 | 3 | 10 | |||||
| >75% corneal depth | 10 | 9 | 4 | 15 | |||||
| Corneal edema | 1.64 (0.37–7.25) | 0.52 | 0.89 (0.16–4.85) | 0.9 | |||||
| 0–75% cornea | 4 | 9 | 3 | 10 | |||||
| >75% cornea | 8 | 11 | 4 | 15 | |||||
| Keratomalacia | 0.47 (0.08–2.81) | 0.41 | 3 (0.5–17.95) | 0.23 | |||||
| Not present/Not severe | 10 | 6 | 4 | 20 | |||||
| Severe keratomalacia | 2 | 2 | 3 | 5 | |||||
| Anterior chamber reaction | 5 (0.87–28.86) | 0.07 | 0.75 (0.14–4.13) | 0.74 | |||||
| Not present/Aqueous flare | 2 | 14 | 3 | 9 | |||||
| Hypopyon/Hyphema | 10 | 11 | 4 | 16 | |||||
Asterisks (*) indicate statistically significant.